Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NINFA-AD

Financiado

Cerrado

Neuropsychiatric Impairments and Neurotransmitter-related Functional Alterations...

Neuropsychiatric Impairments and Neurotransmitter-related Functional Alterations in Alzheimer’s Disease Depressed mood, agitation, false beliefs, lack of motivation and other alterations in behaviour, usually named with the umbrella term of neuropsychiatric symptoms (NPS), are commonly observed in people with Alzheimer’s disease (AD... ver más

31/05/2027

UNIVERSITA DEGLI S...

Presupuesto desconocido

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PARMA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2025-06-01

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 Expected Outcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

UNIVERSITA DEGLI STUDI DI PA...

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 23 meses Fecha Inicio: 2025-06-01
Fecha Fin: 2027-05-31

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PARMA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Depressed mood, agitation, false beliefs, lack of motivation and other alterations in behaviour, usually named with the umbrella term of neuropsychiatric symptoms (NPS), are commonly observed in people with Alzheimer’s disease (AD). NPS are highly prevalent in people with AD (35-85%) and increase the risk of dementia by up to 10 times. The onset of NPS may even precede that of cognitive deficits and predict subsequent cognitive decline. Although not all patients experience NPS and some experience only very mild symptoms, clarifying AD aetiology is of primary importance to improve early diagnosis, provide better care and mitigate the economic burden of dementia. The neural changes associated with NPS in AD are still unclear and, consequently, wide consensus on the best treatment strategies is lacking. Since the earliest accumulation of AD pathology is observed in the nuclei involved in the production of neurotransmitters, the NINFA-AD project aims to investigate whether alterations in brain functioning influenced by abnormalities in different neurotransmitter pathways may be associated with NPS in people either with or at risk for AD. This aim will be pursued by applying an innovative interdisciplinary approach combining functional magnetic resonance with positron emission tomography imaging, fluid AD biomarkers and cognitive data. The NINFA-AD project will provide novel hypothesis-based insights on the cause of these symptoms that will lead to more efficient treatments and improvements in patients' prognosis. Moreover, the findings could be exploited to develop more informative biomarkers to be used in trials to test the mechanisms of action and effectiveness of novel interventions targeting behavioural problems in AD.

Conecta tu I+D

Entra hoy

Forgot your password?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores